The current COVID-19 variant surveillance program is offered at John F. Kennedy International Airport, Newark-Liberty International Airport, San Francisco International Airport, and is now expanding to Hartsfield-Jackson Atlanta International Airport

NEW YORK, Nov. 30, 2021 (GLOBE NEWSWIRE) — XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness company, today announced through a joint effort with the Centers for Disease Control and Prevention (CDC) and Ginkgo Bioworks (NYSE: DNA), the expansion of its current COVID-19 variant surveillance program to detect the new Omicron variant through its XpresCheck subsidiary.

On Saturday, November 27, the White House announced new travel restrictions applicable to eight African countries in response to a…

Source